MAX BioPharma

MAX BioPharma Develops Novel Small Molecule Lipids to Treat Lethal and Debilitating Diseases. The company’s developed oxycholesterols have the ability to stimulate bone growth, inhibit cancer cell growth, and suppress their metastatic potential, enabling physicians to treat pancreatic cancer, breast cancer, and hematologic malignancies.